BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1823 related articles for article (PubMed ID: 30146330)

  • 1. Alcohol use and burden for 195 countries and territories, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.
    GBD 2016 Alcohol Collaborators
    Lancet; 2018 Sep; 392(10152):1015-1035. PubMed ID: 30146330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.
    GBD 2017 Risk Factor Collaborators
    Lancet; 2018 Nov; 392(10159):1923-1994. PubMed ID: 30496105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Global burden of 87 risk factors in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019.
    GBD 2019 Risk Factors Collaborators
    Lancet; 2020 Oct; 396(10258):1223-1249. PubMed ID: 33069327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.
    GBD 2021 Risk Factors Collaborators
    Lancet; 2024 May; 403(10440):2162-2203. PubMed ID: 38762324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.
    GBD 2016 Risk Factors Collaborators
    Lancet; 2017 Sep; 390(10100):1345-1422. PubMed ID: 28919119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Smoking prevalence and attributable disease burden in 195 countries and territories, 1990-2015: a systematic analysis from the Global Burden of Disease Study 2015.
    GBD 2015 Tobacco Collaborators
    Lancet; 2017 May; 389(10082):1885-1906. PubMed ID: 28390697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The global, regional, and national burden of oesophageal cancer and its attributable risk factors in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.
    GBD 2017 Oesophageal Cancer Collaborators
    Lancet Gastroenterol Hepatol; 2020 Jun; 5(6):582-597. PubMed ID: 32246941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.
    GBD 2017 Disease and Injury Incidence and Prevalence Collaborators
    Lancet; 2018 Nov; 392(10159):1789-1858. PubMed ID: 30496104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015.
    GBD 2015 Chronic Respiratory Disease Collaborators
    Lancet Respir Med; 2017 Sep; 5(9):691-706. PubMed ID: 28822787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019.
    GBD 2019 Diseases and Injuries Collaborators
    Lancet; 2020 Oct; 396(10258):1204-1222. PubMed ID: 33069326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017: a systematic analysis for the Global Burden of Disease Study 2017.
    GBD 2017 Causes of Death Collaborators
    Lancet; 2018 Nov; 392(10159):1736-1788. PubMed ID: 30496103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The global burden of disease attributable to alcohol and drug use in 195 countries and territories, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.
    GBD 2016 Alcohol and Drug Use Collaborators
    Lancet Psychiatry; 2018 Dec; 5(12):987-1012. PubMed ID: 30392731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021.
    GBD 2021 Diabetes Collaborators
    Lancet; 2023 Jul; 402(10397):203-234. PubMed ID: 37356446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.
    GBD 2016 DALYs and HALE Collaborators
    Lancet; 2017 Sep; 390(10100):1260-1344. PubMed ID: 28919118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and attributable health burden of chronic respiratory diseases, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.
    GBD Chronic Respiratory Disease Collaborators
    Lancet Respir Med; 2020 Jun; 8(6):585-596. PubMed ID: 32526187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Global, regional, and national burden of 12 mental disorders in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019.
    GBD 2019 Mental Disorders Collaborators
    Lancet Psychiatry; 2022 Feb; 9(2):137-150. PubMed ID: 35026139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Global, regional, and national burden of neurological disorders, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.
    GBD 2016 Neurology Collaborators
    Lancet Neurol; 2019 May; 18(5):459-480. PubMed ID: 30879893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.
    GBD 2017 Cirrhosis Collaborators
    Lancet Gastroenterol Hepatol; 2020 Mar; 5(3):245-266. PubMed ID: 31981519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Global, regional, and national cancer deaths and disability-adjusted life-years (DALYs) attributable to alcohol consumption in 204 countries and territories, 1990-2019.
    Safiri S; Nejadghaderi SA; Karamzad N; Carson-Chahhoud K; Bragazzi NL; Sullman MJM; Almasi-Hashiani A; Mansournia MA; Collins GS; Kaufman JS; Kolahi AA
    Cancer; 2022 May; 128(9):1840-1852. PubMed ID: 35239973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010.
    Lim SS; Vos T; Flaxman AD; Danaei G; Shibuya K; Adair-Rohani H; Amann M; Anderson HR; Andrews KG; Aryee M; Atkinson C; Bacchus LJ; Bahalim AN; Balakrishnan K; Balmes J; Barker-Collo S; Baxter A; Bell ML; Blore JD; Blyth F; Bonner C; Borges G; Bourne R; Boussinesq M; Brauer M; Brooks P; Bruce NG; Brunekreef B; Bryan-Hancock C; Bucello C; Buchbinder R; Bull F; Burnett RT; Byers TE; Calabria B; Carapetis J; Carnahan E; Chafe Z; Charlson F; Chen H; Chen JS; Cheng AT; Child JC; Cohen A; Colson KE; Cowie BC; Darby S; Darling S; Davis A; Degenhardt L; Dentener F; Des Jarlais DC; Devries K; Dherani M; Ding EL; Dorsey ER; Driscoll T; Edmond K; Ali SE; Engell RE; Erwin PJ; Fahimi S; Falder G; Farzadfar F; Ferrari A; Finucane MM; Flaxman S; Fowkes FG; Freedman G; Freeman MK; Gakidou E; Ghosh S; Giovannucci E; Gmel G; Graham K; Grainger R; Grant B; Gunnell D; Gutierrez HR; Hall W; Hoek HW; Hogan A; Hosgood HD; Hoy D; Hu H; Hubbell BJ; Hutchings SJ; Ibeanusi SE; Jacklyn GL; Jasrasaria R; Jonas JB; Kan H; Kanis JA; Kassebaum N; Kawakami N; Khang YH; Khatibzadeh S; Khoo JP; Kok C; Laden F; Lalloo R; Lan Q; Lathlean T; Leasher JL; Leigh J; Li Y; Lin JK; Lipshultz SE; London S; Lozano R; Lu Y; Mak J; Malekzadeh R; Mallinger L; Marcenes W; March L; Marks R; Martin R; McGale P; McGrath J; Mehta S; Mensah GA; Merriman TR; Micha R; Michaud C; Mishra V; Mohd Hanafiah K; Mokdad AA; Morawska L; Mozaffarian D; Murphy T; Naghavi M; Neal B; Nelson PK; Nolla JM; Norman R; Olives C; Omer SB; Orchard J; Osborne R; Ostro B; Page A; Pandey KD; Parry CD; Passmore E; Patra J; Pearce N; Pelizzari PM; Petzold M; Phillips MR; Pope D; Pope CA; Powles J; Rao M; Razavi H; Rehfuess EA; Rehm JT; Ritz B; Rivara FP; Roberts T; Robinson C; Rodriguez-Portales JA; Romieu I; Room R; Rosenfeld LC; Roy A; Rushton L; Salomon JA; Sampson U; Sanchez-Riera L; Sanman E; Sapkota A; Seedat S; Shi P; Shield K; Shivakoti R; Singh GM; Sleet DA; Smith E; Smith KR; Stapelberg NJ; Steenland K; Stöckl H; Stovner LJ; Straif K; Straney L; Thurston GD; Tran JH; Van Dingenen R; van Donkelaar A; Veerman JL; Vijayakumar L; Weintraub R; Weissman MM; White RA; Whiteford H; Wiersma ST; Wilkinson JD; Williams HC; Williams W; Wilson N; Woolf AD; Yip P; Zielinski JM; Lopez AD; Murray CJ; Ezzati M; AlMazroa MA; Memish ZA
    Lancet; 2012 Dec; 380(9859):2224-60. PubMed ID: 23245609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 92.